Advertisement
Advertisement
LYEL
Lyell Immunopharma, Inc. Common Stock
10.53
USDSponsored
-0.62
-5.56%
Sep 23, 15:59 UTC -4
Closed
After-Market
10.54
+0.01
+0.09%
LYEL Earnings Reports
Positive Surprise Ratio
LYEL beat 16 of 21 last estimates.
76%
Next Report
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$2.38K
/-$2.11
Implied change from Q2 26 (Revenue/ EPS)
-40.60%
/+9.90%
Implied change from Q3 25 (Revenue/ EPS)
-84.16%
/-0.94%
Lyell Immunopharma, Inc. Common Stock earnings per share and revenue
On Aug 06, 2026, LYEL reported earnings of -1.92 USD per share (EPS) for Q2 26, beating the estimate of -2.05 USD, resulting in a 6.70% surprise. Revenue reached 4.00 thousand, compared to an expected 3.35 thousand, with a 19.23% difference. The market reacted with a +3.52% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -2.11 USD, with revenue projected to reach 2.38 thousand USD, implying an increase of 9.90% EPS, and decrease of -40.60% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-Actual
-$0.54
Surprise
-
FAQ
What were Lyell Immunopharma, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Lyell Immunopharma, Inc. Common Stock reported EPS of -$1.92, beating estimates by 6.7%, and revenue of $4.00K, 19.23% above expectations.
How did the market react to Lyell Immunopharma, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 3.52%, changed from $14.21 before the earnings release to $14.71 the day after.
When is Lyell Immunopharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Lyell Immunopharma, Inc. Common Stock's next earnings report?
Based on 4
analysts, Lyell Immunopharma, Inc. Common Stock is expected to report EPS of -$2.11 and revenue of $2.38K for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.